VIEMED HEALTHCARE, INC.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
VMD$8.98+0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Income
VIEMED HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Expressed in thousands of U.S. Dollars, except share and per share amounts)(Unaudited)
| Three Months Ended September 30, · Nine Months Ended September 30, | |||||
|---|---|---|---|---|---|
| Note | 2025 | 2024 | 2025 | 2024 | |
| Revenue | 2 | $71,914 | $58,004 | $194,099 | $163,562 |
| Cost of revenue | 30,569 | 23,633 | 82,744 | 66,497 | |
| Gross profit | $41,345 | $34,371 | $111,355 | $97,065 | |
| Operating expenses | |||||
| Selling, general and administrative | 31,919 | 26,671 | 89,147 | 77,988 | |
| Research and development | 775 | 757 | 2,419 | 2,265 | |
| Stock-based compensation | 8 | 2,180 | 1,712 | 6,832 | 4,764 |
| Depreciation and amortization | 397 | 348 | 1,098 | 1,140 | |
| Loss (gain) on disposal of property and equipment | 476 | (469) | (2,528) | (801) | |
| Other expense (income), net | (44) | (276) | (191) | 261 | |
| Income from operations | $5,642 | $5,628 | $14,578 | $11,448 | |
| Non-operating income and expenses | |||||
| Income (loss) from investments | — | 96 | — | (954) | |
| Interest expense, net | 6 | (507) | (225) | (818) | (629) |
| Net income before taxes | 5,135 | 5,499 | 13,760 | 9,865 | |
| Provision for income taxes | 10 | 1,535 | 1,594 | 4,200 | 2,880 |
| Net income | $3,600 | $3,905 | $9,560 | $6,985 | |
| Net income attributable to noncontrolling interest | 87 | 27 | 265 | 36 | |
| Net income attributable to Viemed Healthcare, Inc. | $3,513 | $3,878 | $9,295 | $6,949 | |
| Net income per share | |||||
| Basic | 11 | $0.09 | $0.10 | $0.24 | $0.18 |
| Diluted | 11 | $0.09 | $0.10 | $0.23 | $0.17 |
| Weighted average number of common shares outstanding: | |||||
| Basic | 11 | 38,638,660 | 38,870,823 | 39,190,666 | 38,803,887 |
| Diluted | 11 | 40,495,761 | 40,779,414 | 41,086,178 | 40,702,001 |
See accompanying notes to the condensed consolidated financial statements
Page 4
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.